New research shows an investigational monoclonal antibody may have a positive effect not only on the affected eye but also the unaffected eye in patients with acute optic neuritis. Medscape Medical News
Injections Relieve Graves’ Disease Eyelid Complication (CME/CE)
(MedPage Today) — Single injection reduces unsightly swelling and eyelid retraction
Uncategorized
Avedro resubmits NDA for KXL system for corneal cross-linking
Avedro has resubmitted a new drug application for riboflavin ophthalmic solution/KXL system for corneal cross-linking to the FDA, according to a press release. In March, the FDA issued a second complete response letter asking questions about the design…
Uncategorized
Bausch + Lomb to acquire Doctor’s Allergy Formula
Bausch + Lomb has entered into a definitive agreement to acquire Doctor’s Allergy Formula LLC, which will be incorporated into the pharmaceuticals division, according to a press release.“We are committed to delivering meaningful products to serve the needs of the eye care community and their patients, and Doctor’s Allergy Formula is just one example,” Tracy Valorie, senior vice president and general manager of Bausch + Lomb Pharmaceuticals, said in the release. “We congratulate the Doctor’s Allergy Formula team for identifying and successfully addressing this important area of unmet need and look forward to working with them to bring the benefits of this innovative diagnostic test to even more of our customers.”
Uncategorized
Bausch + Lomb to acquire Doctor’s Allergy Formula
Bausch + Lomb has entered into a definitive agreement to acquire Doctor’s Allergy Formula LLC, which will be incorporated into the pharmaceuticals division, according to a press release.“We are committed to delivering meaningful products to serve the needs of the eye care community and their patients, and Doctor’s Allergy Formula is just one example,” Tracy Valorie, senior vice president and general manager of Bausch + Lomb Pharmaceuticals, said in the release. “We congratulate the Doctor’s Allergy Formula team for identifying and successfully addressing this important area of unmet need and look forward to working with them to bring the benefits of this innovative diagnostic test to even more of our customers.”
Uncategorized
Allergan acquires AqueSys, adds Xen45 to pipeline
Allergan has completed the acquisition of AqueSys in an all-cash transaction, according to a press release. The acquisition includes a $300 million up-front payment and potential regulatory approval and commercialization milestone payments related to X…